Post-COVID-19 cholangiopathy: Systematic review

Table 1 Baseline features in 540 patients with post-COVID-19 cholangiopathy, n (%)

Variable	Patients, n = 540 (100)
Sex
Male	69 (12.7)
Female	26 (4.8)
Age > 50 year	66 (12.2)
Liver enzymes
High (> 45)	507 (93.8)
Total bilirubin
High (> 1.2 mg/dL)	343 (63.5)
Alkaline phosphatase
High (> 147 IU/L)	488 (90.3)
Ultrasound findings
Biliary ductal dilatation with fibrosis	225 (41.6)
MRI Findings
Bile duct thickening and enhancement	258 (47.7)
Beading of intrahepatic ducts	247 (45.7)
Peribiliary diffusion	155 (28.7)
Histopathology with secondary sclerosing cholangitis	402 (74.4)
Orthotopic liver transplantation	16 (2.96)

COVID-19: Coronavirus disease 2019; MRI: Magnetic resonance imaging.